# 2026-12884: FDA Collects Data on Nonprescription Drug Timelines

2026-12884, Agency Information Collection Activities; Proposed Collection; Comment Request; Time and Extent Applications for Nonprescription Drug Products, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-06-26, effective Either electronic or written comments on the collection of information must be submitted by August 25, 2026.; PRIA reads it as touching household money (as of 2026-07-03).

- Canonical: https://policyrisk.com/federal-register/2026-12884
- As of: 2026-07-03
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-12884
- Title: Agency Information Collection Activities; Proposed Collection; Comment Request; Time and Extent Applications for Nonprescription Drug Products
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 38724
- Published: 2026-06-26
- Effective: Either electronic or written comments on the collection of information must be submitted by August 25, 2026.
- Comments close: 2026-08-25
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-07-03

## In one line

FDA Collects Data on Nonprescription Drug Timelines

## Summary

The FDA wants your thoughts on how they collect info about nonprescription drug applications, especially about timing and usage. This affects drug makers and anyone interested in over-the-counter meds. You’ve got until August 25, 2026, to share your comments—no fees, just your voice helping shape the process!

## Abstract

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on time and extent applications for nonprescription drug products.

## Effects PRIA read

- OTC Time-and-Extent Applications Ending: benefit, high. If you make or sponsor over-the-counter (OTC) drug products, the FDA says it anticipates no submissions under 21 CFR 330.14 and plans to withdraw the TEA regulations and discontinue the related guidance. When FDA takes those actions it will also request discontinuation of the information collection…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-12884 on federalregister.gov](https://www.federalregister.gov/documents/2026/06/26/2026-12884/agency-information-collection-activities-proposed-collection-comment-request-time-and-extent)
- [2026-12884 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-06-26/pdf/2026-12884.pdf)

## Related
- [Previous: 2026-12883, Solicitation for Public Comments on the Development of an Independent Accredita…](https://policyrisk.com/federal-register/2026-12883)
- [Next: 2026-12885, Agency Information Collection Activities; Submission to the Office of Managemen…](https://policyrisk.com/federal-register/2026-12885)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-12884 (as of 2026-07-03).
